Association of Genetically Predicted Serum Estradiol With Risk of Thromboembolism in Men: A Mendelian Randomization Study

Abstract Context An association was recently reported between genetic markers related to high testosterone and increased risk of thromboembolism in men, but a possible causal role of estradiol for risk of thromboembolism in men remains unknown. Objective This work aimed to determine whether endogenous estradiol has a causal role in thromboembolism in men. Methods A 2-sample mendelian randomization study using gene-based genetic instruments assessed the association between endogenous estradiol genetically predicted by 22 variants in the aromatase CYP19A1 gene region and the risk of thromboembolism (5815 cases) in 170 593 unrelated men of White ancestry in the UK Biobank. The main outcome measure included thromboembolism based on self-reports, hospital episodes, and death. Results Endogenous estradiol genetically predicted by variants in the CYP19A1 gene region was inversely associated with the risk of thromboembolism (odds ratio per SD increase in estradiol 0.74; 95% CI, 0.62-0.90). In contrast, genetic variants in the JMJD1C gene, used as a predictor of high endogenous testosterone, were associated with an increased risk of thromboembolism (odds ratio per SD increase in testosterone 1.39; 95% CI, 1.12-1.72). Subsequent explorative analyses evaluating potential repercussions of thromboembolism revealed that endogenous estradiol genetically predicted by variants in the CYP19A1 gene region was inversely associated with the risk of ischemic stroke (0.68; 95% CI, 0.49-0.95) but not myocardial infarction (0.97; 95% CI, 0.84-1.13). Conclusion Genetically predicted estradiol was inversely associated with the risk of thromboembolism and ischemic stroke in men. The ratio between testosterone and estradiol, determined by CYP19A1 activity, may contribute to the overall impact of sex steroids on thromboembolism in men.

[1]  T. Wilt,et al.  Efficacy and Safety of Testosterone Treatment in Men: An Evidence Report for a Clinical Practice Guideline by the American College of Physicians , 2020, Annals of Internal Medicine.

[2]  L. Heilbronn,et al.  Higher serum sex hormone-binding globulin (SHBG) levels are associated with incident cardiovascular disease (CVD) in men. , 2019, The Journal of clinical endocrinology and metabolism.

[3]  S. Burgess,et al.  Association of genetically predicted testosterone with thromboembolism, heart failure, and myocardial infarction: mendelian randomisation study in UK Biobank , 2019, BMJ.

[4]  N. Roetker,et al.  Prospective Study of Endogenous Hormones and Incidence of Venous Thromboembolism: The Atherosclerosis Risk in Communities Study , 2018, Thrombosis and Haemostasis.

[5]  S. Windahl,et al.  Evidence of a Causal Effect of Estradiol on Fracture Risk in Men , 2018, The Journal of clinical endocrinology and metabolism.

[6]  G. Davey Smith,et al.  Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians , 2018, British Medical Journal.

[7]  Zhenlang Guo,et al.  Association of androgen deprivation therapy with thromboembolic events in patients with prostate cancer: a systematic review and meta-analysis , 2018, Prostate Cancer and Prostatic Diseases.

[8]  D. Kiel,et al.  Genetic Determinants of Circulating Estrogen Levels and Evidence of a Causal Effect of Estradiol on Bone Density in Men , 2018, The Journal of clinical endocrinology and metabolism.

[9]  M. Maggi,et al.  [Testosterone replacement therapy and cardiovascular risk]. , 2017, Giornale italiano di cardiologia.

[10]  Stephen Burgess,et al.  Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods , 2015, Statistics in medicine.

[11]  Mitchell J. Machiela,et al.  LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants , 2015, Bioinform..

[12]  Nuala A Sheehan,et al.  Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome , 2015, Statistics in medicine.

[13]  Tom R. Gaunt,et al.  Improved imputation of low-frequency and rare variants using the UK10K haplotype reference panel , 2015, Nature Communications.

[14]  G. Davey Smith,et al.  Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression , 2015, International journal of epidemiology.

[15]  P. Elliott,et al.  UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.

[16]  G. Hankey,et al.  In older men, higher plasma testosterone or dihydrotestosterone is an independent predictor for reduced incidence of stroke but not myocardial infarction. , 2014, The Journal of clinical endocrinology and metabolism.

[17]  P. Schnohr,et al.  Endogenous sex hormones and risk of venous thromboembolism in women and men , 2014, Journal of thrombosis and haemostasis : JTH.

[18]  S. Bulun.  Aromatase and estrogen receptor α deficiency. , 2014, Fertility and sterility.

[19]  O. Rouaud,et al.  A J-shaped association between plasma testosterone and risk of ischemic arterial event in elderly men: the French 3C cohort study. , 2013, Maturitas.

[20]  Jonathan P. Beauchamp,et al.  GWAS of 126,559 Individuals Identifies Genetic Variants Associated with Educational Attainment , 2013, Science.

[21]  A. Araujo,et al.  Longitudinal changes in testosterone over five years in community-dwelling men. , 2013, The Journal of clinical endocrinology and metabolism.

[22]  S. Boonen,et al.  Comparisons of Immunoassay and Mass Spectrometry Measurements of Serum Estradiol Levels and Their Influence on Clinical Association Studies in Men , 2013, The Journal of clinical endocrinology and metabolism.

[23]  Jianfeng Xu,et al.  Genome-wide association study identifies a new locus JMJD1C at 10q21 that may influence serum androgen levels in men. , 2012, Human molecular genetics.

[24]  A. Silman,et al.  Comparison of serum testosterone and estradiol measurements in 3174 European men using platform immunoassay and mass spectrometry; relevance for the diagnostics in aging men. , 2012, European journal of endocrinology.

[25]  R. Collins.  What makes UK Biobank special? , 2012, The Lancet.

[26]  E. Barrett-Connor,et al.  High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (Osteoporotic Fractures in Men) study in Sweden. , 2011, Journal of the American College of Cardiology.

[27]  D. Kiel,et al.  Genetic Determinants of Serum Testosterone Concentrations in Men , 2011, PLoS genetics.

[28]  I. Njølstad,et al.  Endogenous sex hormones and the prospective association with cardiovascular disease and mortality in men: the Tromsø Study. , 2009, European journal of endocrinology.

[29]  C. Ohlsson,et al.  Estrogens as regulators of bone health in men , 2009, Nature Reviews Endocrinology.

[30]  G. Hankey,et al.  Lower testosterone levels predict incident stroke and transient ischemic attack in older men. , 2009, The Journal of clinical endocrinology and metabolism.

[31]  J. Hansen,et al.  Endogenous sex hormone levels in men are not associated with risk of venous thromboembolism: the Tromso study. , 2009, European journal of endocrinology.

[32]  George Davey Smith,et al.  Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology , 2008, Statistics in medicine.

[33]  T. Fears,et al.  Reproducibility of Serum Sex Steroid Assays in Men by RIA and Mass Spectrometry , 2007, Cancer Epidemiology Biomarkers & Prevention.

[34]  S. Cummings,et al.  Comparison of methods to measure low serum estradiol levels in postmenopausal women. , 2006, The Journal of clinical endocrinology and metabolism.

[35]  S. Deitcher,et al.  Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review. , 2004, Archives of internal medicine.

[36]  J. Simard,et al.  Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. , 2003, Endocrine reviews.

[37]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[38]  B. Nordestgaard,et al.  Sex Hormones and Ischemic Stroke: A Prospective Cohort Study and Meta-Analyses. , 2016, The Journal of clinical endocrinology and metabolism.

[39]  A. Meikle.  High Serum Testosterone Is Associated With Reduced Risk of Cardiovascular Events in Elderly Men: The MrOS (Osteoporotic Fractures in Men) Study in Sweden , 2012 .

[40]  F. Drobniewski,et al.  Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women : systematic review and meta-analysis , 2008 .